{
    "2018-11-30": [
        [
            {
                "time": "2018-01-03",
                "original_text": "Understanding Array BioPharma’s Operational Performance",
                "features": {
                    "keywords": [
                        "Array",
                        "BioPharma",
                        "Operational",
                        "Performance"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biopharma"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-04",
                "original_text": "Analysts Remain Bullish on Array BioPharma Stock",
                "features": {
                    "keywords": [
                        "Analysts",
                        "Bullish",
                        "Array",
                        "BioPharma"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "biopharma"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-05",
                "original_text": "An Overview of Array BioPharma Stock",
                "features": {
                    "keywords": [
                        "Overview",
                        "Array",
                        "BioPharma"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biopharma"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-06",
                "original_text": "Key Pharma Players With HIV Focus Ahead of World Aids Day",
                "features": {
                    "keywords": [
                        "Pharma",
                        "HIV",
                        "World Aids Day"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-07",
                "original_text": "Best-Run U.S. Companies of 2018---and How They Got That Way",
                "features": {
                    "keywords": [
                        "Best-Run",
                        "U.S.",
                        "Companies",
                        "2018"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "general business"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-08",
                "original_text": "'Shark Tank' star Kevin O’Leary reveals the type of stocks that should outperform in 2019",
                "features": {
                    "keywords": [
                        "Shark Tank",
                        "Kevin O’Leary",
                        "stocks",
                        "outperform",
                        "2019"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "general market"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-09",
                "original_text": "Report: Developing Opportunities within Unifirst, Royal Caribbean Cruises, Albemarle, Tableau Software, Huami, and Johnson & Johnson — Future Expectations, Projections Moving into 2018",
                "features": {
                    "keywords": [
                        "Unifirst",
                        "Royal Caribbean",
                        "Albemarle",
                        "Tableau Software",
                        "Huami",
                        "Johnson & Johnson",
                        "Opportunities",
                        "Projections",
                        "2018"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "various sectors"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-10",
                "original_text": "Johnson & Johnson (JNJ) Dips More Than Broader Markets: What You Should Know",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "Dips",
                        "Broader Markets"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-11",
                "original_text": "Theravance Pipeline Strong, Plans Yupelri Launch by Year End",
                "features": {
                    "keywords": [
                        "Theravance",
                        "Pipeline",
                        "Yupelri",
                        "Launch",
                        "Year End"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}